Next-generation biomedical sensing through photoacoustic–electrochemical synergy

Modern biomedical sensing increasingly demands technologies capable of capturing structural, functional, and molecular information simultaneously. Photoacoustic (PA) and electrochemical (EC) sensing individually address these needs but exhibit inherent limitations when used alone. PA imaging offers deep-tissue, label-free visualization with high spatiotemporal resolution, yet lacks molecular specificity. Conversely, EC sensing provides quantitative, chemically specific information through electrode functionalization, but struggles with spatial mapping and noninvasive detection. Integrating these complementary modalities establishes a unified framework-Photoacoustic-Electrochemical Synergy (PAECS)-that fuses PA's noninvasive, flow-resolved optical contrast with EC's molecular selectivity and quantitative accuracy. PAECS enables multimodal sensing across scales, improving rare-event detection, dynamic monitoring of metabolic and hemodynamic processes, and mechanistic studies of disease and drug response. Applications include coupling PA flow cytometry with EC microfluidics for circulating tumor cell and biomarker analysis, as well as integrating PA imaging with EC metabolite monitoring for real-time tissue profiling. To realize PAECS, future efforts must address system co-registration, signal decoupling, and biomarker-driven design. By bridging optical, acoustic, and electrochemical information, PAECS represents a transformative step toward comprehensive, multiscale biomedical diagnostics and personalized health monitoring.